January - 2011
Next | Showing Journal 1 of 20 |
Corticosteroid After Etomidate in Critically Ill PatientsJean-Francois Payen, MD, PhD; Clément Dupuis, MD; Thibaut Trouve-Buisson, MD; Marc Vinclair, MD; Christophe Broux, MD; Pierre Bouzat, MD; Céline Genty, BSc; Denis Monneret, MD; Patrice Faure, MD, PhD; Olivier Chabre, MD, PhD; Jean-Luc Bosson, MD, PhD Crit Care Med, 2012, 40(1):29-35 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
January |
Previous Comments
No Comments yet.
Comment
Etomidate is widely regarded as one of the best induction agents available for critically ill patients due to its unparalleled haemodynamic stability. However, it is complicated by the inhibition of corticosteroid synthesis, at least in the first 48 hours post dose.
...